Location permission needed for a better experience.
How can we help you?
EN
Hızlı Randevu
Hastane
Randevusu
Görüntülü Görüşme Randevusu
Education
  • 1997 İstanbul University İstanbul Faculty of Medicine Radyasyon Onkolojisi
  • 1993 İstanbul University İstanbul Faculty of Medicine
Experience
  • 2024 Acıbadem Healthcare Services
  • 1998 - 2011 Marmara University Faculty of Medicine / Radyasyon Onkolojisi Professorü / Radyasyon Onkolojisi Ana Bilim Dalı
  • 2010 Neolife Medical Center / Radyasyon Onkolojisi Professorü
  • 1993 - 1997 İstanbul Cerrahpaşa Faculty of Medicine / Radyasyon Onkolojisi Professorü / Radyasyon Onkolojisi Ana Bilim Dalı
Memberships
  • Türk Radyasyon Onkolojisi Association Yönetim Kurulu üyesi-Genel Sekreter 2009-2010, Yönetim Kurulu üyesi 2011-2012
  • European Organization for Research and Treatment of Cancer (EORTC) Radiation Oncology Group
  • Türk Onkoloji Grubu TOG-Santral Sinir Sistemi Çalışma Grubu Başkanı 2007-2010
  • American Society for Radiation Oncology (ASTRO)
  • Türk Akciğer Kanseri Association (TAKD)
  • American Society of Clinical Oncology (ASCO)
  • European Association of Neurooncology (EANO) Yönetim Kurulu-Executive Board üyesi 2010-2014
  • Nöroonkoloji Association Yönetim Kurulu üyesi- Başkan Yardımcısı 2013-2015, Başkan 2015
  • Rare Cancer Network
  • European Society for Therapeutic Radiology and Oncology (ESTRO)
  • Romanya Üroloji Association Onursal üyelik (Haziran 2015)
PUBLICATIONS
  • Heidelberg University Hospital, about the Phase-ll Trial Evaluating Carbon Ion Radiotherapy for the Treatment of Primary Glioblastoma (CLEOPATRA) Eur Assoc Neurooncol Mag, 4(1): 47-48, (2014) Abacioglu U. Interview with Dr Stephanie E Combs
  • V30 as a predictor for radiation-induced hypothyroidism: a dosimetric analysis in patients who received radiotherapy to the neck Radiai Oncol, 2014; 9:104 Akgun Z, Atasoy BM, Özen Z, Yavuz D, Gulluoglu B, Sengoz M, Abacioglu U
  • Critical appraisal of RapidArc radiosurgery with flattening filter free photon beams for benign brain lesions in comparison to GammaKnife: a treatment planning study Radiai Oncol, 2014; 9:119. Abacioglu U, Ozen Z, Yilmaz M, Arifoglu A, Gunhan B, Kayalilar N, Peker S, Sengoz M, Gurdalli S, Cozzi L
  • MSKCC, about the RTOG 1114-Phase II randomized Study of Chemotherapy with and without Low-Dose WBRT for Primary Central Nervous Lymphoma Eur Assoc Neurooncol Mag, 4(3): 130-131, (2014). Abacioglu U. Interview with Dr. Antonio Omuro
  • MD, VU University Medical Center, Amsterdam, about the Randomised Trial on Internet-Based Treatment of Depressive Symptoms in Glioma Patients Eur Assoc Neurooncol Mag, 4(2): 90-91, (2014) Abacioglu U. Interview with Florien Boele, MSc, and Martin Klein
.
.
.

Contact Us

Fill out the form below for your information requests

As Acıbadem Healthcare Group, you can report your requests, suggestions, thanks and complaints by filling out the form below or by contacting us at +90 538 685 39 52 so that we can provide you with a better and higher quality service.

See More
See More
Security Code

INFORMATION NOTICE ON THE PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. and its controlling and affiliated companies listed in Annex-1 (each referred to individually as the "Company" and collectively as the "Companies") process your general and/or special category personal data (including but not limited to health data) ("Personal Data") in the capacity of Data Controller under the Personal Data Protection Law No. 6698 ("Law") and related legislation. Processing of Personal Data is carried out in accordance with the framework outlined below and in compliance with the Fundamental Law on Health Services No. 3359, the Decree Law No. 663 on the Organization and Duties of the Ministry of Health and its Affiliated Institutions, the Regulation on the Provision of Remote Health Services, the Private Hospitals Regulation, the Ministry of Health regulations, and other relevant legislation.

I. Acquisition, Processing, and Purposes of Processing Personal Data

Your Personal Data is obtained through verbal, written, visual, or electronic channels (such as our website, mobile applications, and call center) for the purposes of protecting public health, preventive medicine, medical diagnosis, treatment and care services, and the planning and management of healthcare services and their financing, in alignment with the Company's fields of activity. The Personal Data processed by the Company, including but not limited to the following, is collected and processed proportionally and in connection with these purposes:

Your Personal Data may be processed under the conditions specified in Articles 5 and 6 of the Law for the following purposes:

II. Transfer of Personal Data

Your Personal Data may be shared with:

III. Method and Legal Basis for Collecting Personal Data

Your Personal Data is collected through verbal, written, visual, or electronic means for the lawful execution of the Company's activities and compliance with contractual and legal obligations. The legal basis for collection includes:

As per Article 6 - (3) of the Law, personal data related to health and sexual life may be processed without explicit consent by persons or institutions subject to confidentiality obligations for public health protection, preventive medicine, medical diagnosis, treatment, and care services, as well as the planning and management of healthcare financing.

IV. Your Rights Regarding the Protection of Personal Data

Under Article 11 of the Law, you have the right to:

V. Data Security

The Companies ensure the security of Personal Data by implementing necessary technical and administrative measures in accordance with information security standards and procedures.

VI. Complaints and Contact Information

To exercise your rights under the Law, you may submit a request through the methods specified in the "Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. Data Subject Application Form" available at https://www.acibadem.com.tr/acibademonline/images/Ac%C4%B1badem_Veri_Sahibi_Basvuru_Formu.pdf.

Requests can be submitted by mail, notarized document, or secure electronic means to:

ANNEX-1: List of Companies

 

TOP x""